LII Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lennox International is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available and a willingness to act quickly. The stock has solid fundamental support from analyst upgrades, hedge fund buying, and a favorable Congress trade read, but the current technical setup is still mixed-to-bearish and the options tape leans cautious. My direct view is hold rather than buy today; the setup is decent, but not compelling enough for an immediate long-term purchase at the current pre-market price.
The short-term trend is not strong. MACD histogram is negative at -1.954 and still below zero, showing downside momentum remains in place. RSI_6 at 47.93 is neutral, so the stock is not oversold enough to offer a clear dip-buy signal. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which usually means the stock is still in a weaker trend structure. Price is near the pivot at 496.87, with pre-market price at 501.58, so it is hovering close to equilibrium rather than breaking out. Immediate resistance is 513.75, then 524.19; support is 479.99 and 469.55. The technical picture does not confirm a fresh high-conviction entry.
Analyst sentiment is constructive overall, with multiple firms raising targets after Q1 results and Vertical Research upgrading to Buy. Oppenheimer remains Outperform and sees Lennox’s growth plan and AI/digital initiatives as meaningful long-term drivers. Hedge funds have been buying aggressively, with buying up 2261.11% over the last quarter. Congress trading data is also positive, showing 1 purchase and 0 sales in the past 90 days, which is a modest bullish signal. The company also beat Q1 top-line and bottom-line consensus and reiterated FY26 EPS/free cash flow guidance.
There has been no new news in the last week, so there is no fresh event-driven catalyst. Several analysts still carry Neutral or Equal Weight views, including Baird and BNP Paribas, and Wells Fargo cut its target to 480, reflecting caution around demand and macro uncertainty. Technically, the stock remains below a bullish trend confirmation and the moving averages are bearish. Options flow also leans defensive with a higher put volume ratio.
Latest quarter season: Q1 2026. The company beat top-line and bottom-line consensus and reiterated FY26 EPS and free cash flow guidance. Oppenheimer noted that higher top-line results helped offset inflation, and that pricing actions to recover tariffs/inflation are unlikely to materially change FY26 volume trajectory. Because detailed financial snapshot data was unavailable, the main takeaway is that the latest quarter was solid and management maintained its outlook, which supports the long-term thesis.
Analyst trend is mostly positive recently. Oppenheimer raised its target to $650 and kept Outperform. Vertical Research upgraded to Buy with a $600 target. Barclays slightly trimmed its target to $597 but stayed Overweight. Baird raised its target to $550 while staying Neutral, BNP Paribas started at Neutral with $535, and Wells Fargo cut to $480 with Equal Weight. Overall, Wall Street is constructive on the business, but the view is split between bullish upside and neutral caution rather than unanimous conviction.
